In contrast, earlier studies reported that AZM reduced IL-33 gene expression in bronchoalveolar lavage (BAL) fluid from an unstimulated mouse model of asthma, where multiple cell types might contribute to IL-33 release, potentially explaining the conflicting results (35). This evidence concerns the gene IL33 and asthma.